Cargando…
Anti-Transforming Growth Factor ß Antibody Treatment Rescues Bone Loss and Prevents Breast Cancer Metastasis to Bone
Breast cancer often metastasizes to bone causing osteolytic bone resorption which releases active TGFβ. Because TGFβ favors progression of breast cancer metastasis to bone, we hypothesized that treatment using anti-TGFβ antibody may reduce tumor burden and rescue tumor-associated bone loss in metast...
Autores principales: | Biswas, Swati, Nyman, Jeffry S., Alvarez, JoAnn, Chakrabarti, Anwesa, Ayres, Austin, Sterling, Julie, Edwards, James, Rana, Tapasi, Johnson, Rachelle, Perrien, Daniel S., Lonning, Scott, Shyr, Yu, Matrisian, Lynn M., Mundy, Gregory R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3214031/ https://www.ncbi.nlm.nih.gov/pubmed/22096521 http://dx.doi.org/10.1371/journal.pone.0027090 |
Ejemplares similares
-
Doxorubicin-Mediated Bone Loss in Breast Cancer Bone Metastases Is Driven by an Interplay between Oxidative Stress and Induction of TGFβ
por: Rana, Tapasi, et al.
Publicado: (2013) -
Correction: Doxorubicin-Mediated Bone Loss in Breast Cancer Bone Metastases Is Driven by an Interplay between Oxidative Stress and Induction of TGFβ
por: Rana, Tapasi, et al.
Publicado: (2013) -
Local Low-Dose Lovastatin Delivery Improves the Bone-Healing Defect Caused by Nf1 Loss of Function in Osteoblasts
por: Wang, Weixi, et al.
Publicado: (2010) -
Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1
por: de la Croix Ndong, Jean, et al.
Publicado: (2014) -
Daily parathyroid hormone administration enhances bone turnover and preserves bone structure after severe immobilization‐induced bone loss
por: Harlow, Lauren, et al.
Publicado: (2017)